CWA Asset Management Group LLC Has $5.14 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

CWA Asset Management Group LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 10,162 shares of the healthcare conglomerate’s stock after selling 113 shares during the period. CWA Asset Management Group LLC’s holdings in UnitedHealth Group were worth $5,140,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group during the third quarter valued at about $27,000. Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. West Financial Advisors LLC bought a new position in UnitedHealth Group during the third quarter worth about $32,000. Quarry LP grew its position in shares of UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares in the last quarter. Finally, VitalStone Financial LLC grew its position in shares of UnitedHealth Group by 600.0% during the 2nd quarter. VitalStone Financial LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $36,000 after purchasing an additional 60 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.5 %

Shares of NYSE:UNH traded up $2.54 during trading hours on Monday, hitting $515.54. 1,104,317 shares of the company’s stock traded hands, compared to its average volume of 2,766,578. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The business has a fifty day moving average price of $559.83 and a 200-day moving average price of $561.31. The firm has a market capitalization of $474.44 billion, a P/E ratio of 33.59, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.56 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.63%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analyst Weigh In

UNH has been the subject of several research reports. KeyCorp began coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Cantor Fitzgerald boosted their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. TD Cowen increased their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Finally, Stephens upped their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $627.58.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.